Nuvectis Pharma, Inc.
NVCT
$0.18
Change (1 day)
$12.10
Year High
$4.44
Year Low
Categories
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
Stock price history for Nuvectis Pharma, Inc. (NVCT)
Highest end of day price: $20.44 USD on 2022-05-17
Lowest end of day price: $3.25 USD on 2022-02-04